SE8803143L - Alternativa energisubstrat - Google Patents

Alternativa energisubstrat

Info

Publication number: SE8803143L
Authority: SE; Sweden
Prior art keywords: ester; carbon atoms; alternative energy; energy substrate; bound
Prior art date: 1988-09-07

Application number

SE8803143A

Other languages

Unknown language ( )

English (en)

Swedish (sv)

Other versions

SE8803143D0 (sv

Inventor

S Lindgren

K Campos

K Granelli

C Grimfors

M Johansson

Original Assignee

Kabivitrum Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-09-07

Filing date

1988-09-07

Publication date

1990-03-08

1988-09-07 Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab

1988-09-07 Priority to SE8803143A priority Critical patent/SE8803143L/

1988-09-07 Publication of SE8803143D0 publication Critical patent/SE8803143D0/xx

1989-09-06 Priority to AU41896/89A priority patent/AU4189689A/en

1989-09-06 Priority to EP89909889A priority patent/EP0408674A1/fr

1989-09-06 Priority to EP89850291A priority patent/EP0366632A1/fr

1989-09-06 Priority to JP1509226A priority patent/JPH03501023A/ja

1989-09-06 Priority to PCT/SE1989/000472 priority patent/WO1990002726A1/fr

1990-03-08 Publication of SE8803143L publication Critical patent/SE8803143L/

Links

239000000758 substrate Substances 0.000 title abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 2
150000002148 esters Chemical class 0.000 abstract 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
229940126062 Compound A Drugs 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
230000000845 anti-microbial effect Effects 0.000 abstract 1
239000004599 antimicrobial Substances 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
125000004429 atom Chemical group 0.000 abstract 1
125000002843 carboxylic acid group Chemical group 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000002184 metal Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
235000015097 nutrients Nutrition 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
- C07C59/195—Acetoacetic acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Nutrition Science (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Virology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SE8803143A 1988-09-07 1988-09-07 Alternativa energisubstrat SE8803143L (sv)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
SE8803143A SE8803143L (sv)	1988-09-07	1988-09-07	Alternativa energisubstrat
AU41896/89A AU4189689A (en)	1988-09-07	1989-09-06	Alternative energy substrate
EP89909889A EP0408674A1 (fr)	1988-09-07	1989-09-06	Variantes de substrats energetiques
EP89850291A EP0366632A1 (fr)	1988-09-07	1989-09-06	Substrat d'énergie alternatif
JP1509226A JPH03501023A (ja)	1988-09-07	1989-09-06	代替エネルギー基質
PCT/SE1989/000472 WO1990002726A1 (fr)	1988-09-07	1989-09-06	Variantes de substrats energetiques

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE8803143A SE8803143L (sv)	1988-09-07	1988-09-07	Alternativa energisubstrat

Publications (2)

Publication Number	Publication Date
SE8803143D0 SE8803143D0 (sv)	1988-09-07
SE8803143L true SE8803143L (sv)	1990-03-08

Family

ID=20373250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8803143A SE8803143L (sv)	1988-09-07	1988-09-07	Alternativa energisubstrat

Country Status (5)

Country	Link
EP (2)	EP0366632A1 (fr)
JP (1)	JPH03501023A (fr)
AU (1)	AU4189689A (fr)
SE (1)	SE8803143L (fr)
WO (1)	WO1990002726A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7041840B2 (en)	2002-12-18	2006-05-09	Alberta Research Council Inc.	Antioxidant triacylglycerols and lipid compositions
DE102005018642B4 (de) *	2005-04-15	2011-04-07	Bio Mac- Privatinstitut für medizinische und zahnmedizinische Forschung, Entwicklung und Diagnostik GmbH	Verwendung von Verbindungen zur Hemmung der Glyoxalasen
WO2006108679A2 (fr) *	2005-04-15	2006-10-19	Biomac Privatinstitut Für Medizinische Und Zahnmedizinische Forschung, Entwicklung Und Diagnostik Gmbh	Matieres et compositions pharmaceutiques destinees a inhiber les glyoxalases et utilisation de celles-ci pour lutter contre le cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB903944A (en) *	1960-02-01	1962-08-22	Pfizer & Co C	Manufacture of pyruvic acid esters
DE2335215B2 (de) *	1972-07-13	1979-04-05	The Johns Hopkins University, Baltimore, Md. (V.St.A.)	Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
GB1442154A (en) *	1973-04-30	1976-07-07	Walser M	Composition for promotion of protein synthesis and suppression of urea formation in the body
SU598869A1 (ru) *	1976-12-06	1978-03-25	Краснодарский политехнический институт	Способ получени эфиров левулиновой кислоты
SU745891A1 (ru) *	1977-12-05	1980-07-07	Ленинградский Ордена Трудового Красного Знамени Технологический Институт Им. Ленсовета	Способ получени кетоалкановых кислот
SU789504A1 (ru) *	1979-03-03	1980-12-23	Ярославский политехнический институт	Способ получени алифатических -кетокислот
GB2088354A (en) *	1980-11-07	1982-06-09	Shell Int Research	Preparation of a-pivaloyl acetic esters
DE3144079A1 (de) *	1981-11-06	1983-05-19	Basf Ag, 6700 Ludwigshafen	(gamma)-alkoxy-(delta)-ketosaeure-ester und -nitrile, deren herstellung und cyclisierung zu (gamma)- und (delta)-lactonen
DE3334208A1 (de) *	1983-09-22	1985-04-04	Henkel Kgaa	Ketocarbonsaeureester und ihre verwendung in kosmetika
US4752619A (en) *	1985-12-23	1988-06-21	The Johns Hopkins University	Nutritional supplement for treatment of uremia
GB8600822D0 (en) *	1986-01-15	1986-02-19	Unilever Plc	Treatment of skin disorders

1988
- 1988-09-07 SE SE8803143A patent/SE8803143L/ not_active Application Discontinuation
1989
- 1989-09-06 JP JP1509226A patent/JPH03501023A/ja active Pending
- 1989-09-06 WO PCT/SE1989/000472 patent/WO1990002726A1/fr not_active Ceased
- 1989-09-06 AU AU41896/89A patent/AU4189689A/en not_active Abandoned
- 1989-09-06 EP EP89850291A patent/EP0366632A1/fr active Pending
- 1989-09-06 EP EP89909889A patent/EP0408674A1/fr not_active Withdrawn

Also Published As

Publication number	Publication date
EP0408674A1 (fr)	1991-01-23
EP0366632A1 (fr)	1990-05-02
JPH03501023A (ja)	1991-03-07
WO1990002726A1 (fr)	1990-03-22
AU4189689A (en)	1990-04-02
SE8803143D0 (sv)	1988-09-07

Legal Events

Date

Code

Title

Description

1995-02-28

NAV

Patent application has lapsed

Ref document number: 8803143-0

Effective date: 19930501

Publication	Publication Date	Title
ES2131207T3 (es)	1999-07-16	Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
ATE12638T1 (de)	1985-04-15	Mb-530b derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2073529T3 (es)	1995-08-16	Inhibidor de fosfolipasa a2, microorganismos que producen este inhibidor y procedimiento para su produccion.
MY114765A (en)	2003-01-31	Preparation for epidermis
ATE16488T1 (de)	1985-11-15	M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
ATE141588T1 (de)	1996-09-15	Polymerisationsinhibitoren für acrylsäure und ester
ES8700673A1 (es)	1986-10-16	Un procedimiento para preparar derivados de acido griseolico
ES2074828T3 (es)	1995-09-16	Copoliester degradable de 4-hidroxi-prolina y composicion farmaceutica que lo contiene.
PT90986A (pt)	1989-12-29	Processo para a preparacao de esteres de estramustina e de composicoes farmaceuticas que os contem
SE8803143L (sv)	1990-03-08	Alternativa energisubstrat
AU2651597A (en)	1997-11-26	Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
ATE39487T1 (de)	1989-01-15	Ml-236b-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU586477B2 (en)	1989-07-13	Hexenoic acids
ATE110569T1 (de)	1994-09-15	Pharmazeutische zusammensetzung zur verbesserung von dysuria.
GB1514389A (en)	1978-06-14	Glycerides with antibacterial properties
ES2076369T3 (es)	1995-11-01	Procedimiento para la separacion de racematos de esteres de acidos 4-aril-2-oxo-pirrolidina-3-carboxilicos.
WO2002002098A3 (fr)	2002-12-12	Procede et composition
KR950702566A (ko)	1995-07-29	사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds)
ATE309212T1 (de)	2005-11-15	Optisch aktive 1-phenylpyrrolidonderivate
AU2742288A (en)	1989-06-29	Novel compound effective as cerebral insufficiency improver
MX9706923A (es)	1998-08-30	Nuevos compuestos de ester, composiciones pesticidas que contienen los mismos y compuestos intermedios para la sintesis de los mismos.